Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $14.65 and last traded at $14.46, with a volume of 1274427 shares. The stock had previously closed at $14.50.
Silverback Therapeutics Trading Down 0.3 %
The stock’s 50-day moving average is $12.20 and its 200-day moving average is $10.22. The stock has a market cap of $521.40 million, a price-to-earnings ratio of -5.92 and a beta of 0.60.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- The 3 Best Retail Stocks to Shop for in August
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Upcoming IPO Stock Lockup Period, Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Invest in the Best Canadian Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
